AFT Pharma strikes licensing deal with Swiss company to sell Maxigesic in 69 countries

Fiona Rotherham
Sun, 28 Feb 2016

By Fiona Rotherham Feb. 29 (BusinessDesk) -  AFT Pharmaceuticals has reached agreement with privately-owned Swiss headquartered multinational pharmaceutical company Acino Pharma AG to out-license the Auckland drug-maker’s main product, the patented combination painkiller Maxigesic to a further 69 countries. The shares rose.  The agreement is to sell all oral dose forms of Maxigesic and Maxigesic 1V in four geographic regions – Saudi Arabia and Yemen, Central America and the Caribbean, Africa, and North Africa and Levant. AFT markets more...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Law & Regulation
Misconduct complaint upheld against quake claims lawyer
Victoria Young | Thu, 24 Sep 2020

However, Grant Shand says it's a win. 

Policy
Govt's pumped hydro scheme 'disturbing, dreamland' project - Mercury
Gavin Evans | Thu, 24 Sep 2020

The government’s pursuit of a $4 billion-plus pumped hydro scheme in Central Otago is a “disturbing blast from the past,” Mercury director warns.

Policy
Partnerships vital for 'massive' emission reduction investment
Gavin Evans | Thu, 24 Sep 2020

A "massive" investment will be required to decarbonise the NZ economy, so partnerships will be vital, says the head of the Climate Change Commission.

Partner Content
The whole story behind good investment decisions

If there was ever a time when strong financial metrics were the single trademark of a good company, that time has long passed. Responsible investors need to know beyond the profit a company will generate this year or next.

Sponsored
Canon Business: Premium solutions for Commercial Bay

Precinct Properties is the largest owner and developer of premium inner-city business space in Auckland and Wellington, its latest flagship success is the transformational Commercial Bay on Auckland's waterfront. Canon knew that for such a high-calibre client, only a premium bespoke purpose-built solution would suffice when it came to providing market-leading print, mail and courier services to over 10,000 tenants in the development.